Gold Mining News – Lifestyle
Home
Sample Page
Author:
AC Immune SA
AC Immune Announces Retirement of CEO Dr Andrea Pfeifer at Upcoming AGM
May 12, 2026
AC Immune First Quarter 2026 Financial and Corporate Updates
April 30, 2026
AC Immune Initiates Final Cohort in Ongoing Phase 1b/2 ABATE Trial of Anti-Abeta Active Immunotherapy to Treat Alzheimer’s Disease
April 30, 2026
AC Immune Announces Amendment to Morphomer ® Tau License and Collaboration Agreement with Lilly
April 7, 2026
AC Immune Presents First In vivo Images of Brain TDP-43 Pathology from Phase 1 Trial of PET tracer ACI-19626, at AD/PDTM 2026
March 19, 2026
AC Immune Reports Full Year 2025 Financial Results and Provides a Corporate Update
March 13, 2026